Ulcerative Colitis & Crohn’s Disease Clinical Research Study
Current Clinical Studies
Ulcerative Colitis & Crohn’s Disease Clinical Trial Study in Phoenix, AZ
Living with Ulcerative Colitis or Crohn’s Disease can affect nearly every part of daily life. Abdominal pain, urgent bowel movements, fatigue, diarrhea, appetite changes, and unpredictable flare-ups can make working, traveling, exercising, and spending time with family more difficult.
Elite Clinical Studies in Phoenix, Arizona, conducts clinical research to help expand medical knowledge and evaluate investigational approaches for chronic gastrointestinal conditions. Individuals living with Ulcerative Colitis or Crohn’s Disease may have an opportunity to support inflammatory bowel disease research by participating in a clinical trial study.
Understanding Inflammatory Bowel Disease
Ulcerative Colitis and Crohn’s Disease are the two primary forms of inflammatory bowel disease, commonly known as IBD. Although both conditions involve chronic inflammation within the digestive system, they can affect different areas and cause different patterns of symptoms.
IBD should not be confused with irritable bowel syndrome, or IBS. While IBS can produce uncomfortable digestive symptoms, it does not cause the same type of chronic intestinal inflammation associated with Ulcerative Colitis and Crohn’s Disease.
What Is Ulcerative Colitis?
Ulcerative Colitis is a chronic inflammatory condition that affects the inner lining of the large intestine, including the colon and rectum. Inflammation may begin near the rectum and extend continuously through part or all of the colon.
Symptoms can range from mild to severe and may change over time. Some individuals experience periods of active symptoms followed by periods of remission.
Common symptoms may include:
- Persistent or recurring diarrhea
- Blood or mucus in the stool
- Abdominal pain and cramping
- Rectal discomfort or bleeding
- Sudden or frequent urges to have a bowel movement
- Fatigue or reduced energy
- Unintended weight loss
- Loss of appetite
- Fever during periods of active inflammation
Learn more about the current Ulcerative Colitis Clinical Study available through Elite Clinical Studies.
What Is Crohn’s Disease?
Crohn’s Disease is another chronic form of inflammatory bowel disease. Unlike Ulcerative Colitis, Crohn’s Disease can affect any part of the gastrointestinal tract, from the mouth to the anus. However, it commonly affects the end of the small intestine and the beginning of the colon.
Inflammation from Crohn’s Disease may occur in separate areas, leaving healthy tissue between affected sections. It may also extend more deeply into the intestinal wall.
Common symptoms may include:
- Ongoing or recurring diarrhea
- Abdominal pain or tenderness
- Cramping after eating
- Fatigue
- Reduced appetite
- Unintended weight loss
- Blood in the stool
- Fever
- Mouth sores
- Pain or drainage near the anal area
Symptoms vary considerably between individuals. Therefore, a medical professional must determine whether someone has Crohn’s Disease, Ulcerative Colitis, or another gastrointestinal condition.
How IBD Can Affect Daily Life
Because IBD symptoms can be unpredictable, many people must plan daily activities around bathroom access, meals, medication schedules, and energy levels. Flare-ups may interfere with work, school, sleep, exercise, travel, and social activities.
In addition, the uncertainty of recurring symptoms can contribute to stress, frustration, embarrassment, or social isolation. Even during periods when symptoms appear controlled, individuals may worry about when another flare-up could occur.
Research remains important because each person may respond differently to available approaches. Clinical studies allow researchers to collect carefully monitored information that may contribute to a better understanding of these complex conditions.
About the Ulcerative Colitis and Crohn’s Disease Clinical Trial Study
Elite Clinical Studies conducts clinical research under established study protocols and the supervision of qualified research professionals. A clinical study may evaluate an investigational medication, a new use for an existing medication, or another research-based approach.
Participation requirements vary according to the specific study. Before joining, potential volunteers generally complete a screening process so the research team can determine whether the study may be appropriate for them.
Study participation may include:
- A review of medical history and current symptoms
- Study-related examinations or laboratory testing
- Scheduled visits with the clinical research team
- Use of an investigational study medication or procedure
- Monitoring of symptoms and overall health
- Completion of questionnaires or symptom diaries
- Follow-up visits during the research period
The research team explains the study, its requirements, potential risks, possible benefits, and available alternatives before a volunteer decides whether to participate. Participation is voluntary, and individuals are encouraged to ask questions before providing informed consent.
Why Volunteer for Clinical Research?
Clinical trial volunteers play an important role in medical research. Information gathered during a study can help researchers evaluate how an investigational approach works, understand potential side effects, and determine whether additional research should be conducted.
Depending on the study, qualified volunteers may receive:
- Study-related medical care at no cost
- Study-related examinations and laboratory testing
- Monitoring by experienced research professionals
- Access to an investigational study option
- Compensation for study-related time and travel, when applicable
Compensation and study-related services vary. Participation is not guaranteed, and all volunteers must meet the study’s eligibility requirements.
Who May Be Considered?
Eligibility requirements are different for every clinical trial. A study may consider factors such as age, diagnosis, current symptoms, medical history, previous treatments, medications, laboratory findings, and overall health.
You may wish to ask about the study if you:
- Have been diagnosed with Ulcerative Colitis or Crohn’s Disease
- Experience recurring symptoms despite current management
- Have previously used medications for inflammatory bowel disease
- Can attend scheduled appointments in Phoenix
- Are willing to follow the study requirements
Only the research team can determine whether an individual qualifies. Completing an initial form or screening does not require someone to enroll.
Clinical Research in Phoenix, Arizona
Elite Clinical Studies is a multi-specialty clinical research facility serving Phoenix and surrounding Arizona communities. The research team works with study participants throughout the screening, enrollment, treatment, and follow-up process.
You can learn more about Elite Clinical Studies, review the organization’s current clinical studies, or complete the volunteer form to request additional information.
Frequently Asked Questions
What is the difference between Ulcerative Colitis and Crohn’s Disease?
Ulcerative Colitis affects the inner lining of the colon and rectum, usually in a continuous pattern. Crohn’s Disease can affect any part of the digestive tract and may involve separate areas of inflammation. Crohn’s inflammation may also extend deeper into the intestinal wall.
What does “IBD” mean?
IBD stands for inflammatory bowel disease. It is a general term primarily used to describe Ulcerative Colitis and Crohn’s Disease, both of which involve chronic inflammation in the digestive system.
Is IBD the same as IBS?
No. Inflammatory bowel disease and irritable bowel syndrome are different conditions. IBD causes chronic inflammation and may damage digestive tissue. IBS affects bowel function but does not produce the same type of intestinal inflammation.
What are common symptoms of Ulcerative Colitis and Crohn’s Disease?
Common symptoms may include diarrhea, abdominal pain, cramping, fatigue, reduced appetite, unintended weight loss, blood in the stool, and an urgent need to have a bowel movement. Symptoms and severity vary from person to person.
Do I need an official diagnosis to participate?
Specific requirements depend on the study protocol. Some studies require a documented diagnosis of Ulcerative Colitis or Crohn’s Disease. The research team will review your medical history and explain the screening requirements.
What happens during the screening process?
The screening process may include questions about your symptoms, medical history, medications, and previous treatments. Study-related examinations, laboratory testing, or medical record reviews may also be required before eligibility can be determined.
Does completing the screening process mean I must participate?
No. Completing a screening form or speaking with the research team does not require you to enroll. Participation is voluntary, and you may ask questions before deciding whether the study is right for you.
Will I receive study-related care at no cost?
Study-related care, examinations, testing, and investigational products may be provided at no cost when required by the research protocol. The study team will explain which services are included before enrollment.
Will volunteers be compensated?
Qualified participants may receive compensation for study-related time and travel when permitted by the study protocol. Compensation amounts and requirements vary by study.
How long does a clinical trial last?
The length of participation varies by study. Some clinical trials may last several weeks, while others may continue for several months or longer. The research team will explain the expected schedule and number of visits before you enroll.
Can I continue taking my current medications?
Medication requirements vary by study. Do not stop or change any medication unless instructed by a qualified medical professional. The research team will review your medications during screening and explain any study-specific requirements.
Can I leave the study after enrolling?
Yes. Clinical trial participation is voluntary, and participants may withdraw at any time. The study team can explain whether any safety follow-up is recommended after withdrawal.
How is participant privacy protected?
Clinical research sites follow study procedures and applicable privacy requirements when collecting and maintaining participant information. The informed consent process explains how study information may be used and protected.
How do I find out whether I qualify?
Contact Elite Clinical Studies or complete the clinical study volunteer form. A member of the research team can discuss the current study and guide you through the screening process.
Take the Next Step
If you or someone you know has been diagnosed with Ulcerative Colitis or Crohn’s Disease, contact Elite Clinical Studies to ask about current inflammatory bowel disease research opportunities in Phoenix.
Submitting an inquiry does not guarantee eligibility or require participation. A member of the research team can provide information about the study and explain the screening process.
Elite Clinical Studies
4520 E. Indian School Road, Suite 1
Phoenix, AZ 85018
View Elite Clinical Studies on Google Maps
Phone: 602-788-3437
For additional questions, visit the contact page or complete the clinical study volunteer form.
Participation in clinical research is voluntary. Eligibility, study-related care, investigational procedures, visit requirements, and compensation depend on the individual study protocol.
Our Work
Current Clinical Studies
We are constantly receiving new clinical trial studies and update this page often. If you don’t see anything you are interested in below, please fill out our volunteer form or call today to be put on a list to be contacted when a clinical study becomes available for you.
Opiate Addiction
Elite Clinical Studies in Phoenix, AZ, is now enrolling participants for a clinical trial focused on opiate addiction, aiming to explore new treatment options and gather essential data to improve management of this chronic condition. Participants will receive access to cutting-edge treatments, comprehensive medical support, and may be compensated for their time and travel expenses.
Atrial Fibrillation
Elite Clinical Studies in Phoenix, AZ, is now enrolling participants for a clinical trial focused on Atrial Fibrillation (AFib), aiming to explore new treatment options and gather essential data for better management of this condition. Participants will receive access to innovative treatments, comprehensive medical support, and may be compensated for their time and travel expenses.
NERD
Alopecia
Alopecia is a condition where the immune system mistakenly attacks hair follicles, causing hair thinning, patchy bald spots, or complete hair loss. Elite Clinical Studies in Phoenix, AZ, is currently conducting a clinical trial to explore new treatment options for Alopecia, aiming to gather data that could improve its management and care.
Ulcerative Colitis
Chronic Kidney Disease
IBS with Diarrhea
Explore groundbreaking advancements in the field of Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D) through Elite Clinical Studies' innovative IBS Clinical Study, offering qualified Arizona residents the opportunity to contribute to cutting-edge research and potentially improve treatments for this challenging condition.
Gout
Elite Clinical Studies is leading a Gout Clinical Trial study in Phoenix, offering crucial support to physicians in investigating and managing this painful inflammatory arthritis condition, while ensuring regulatory compliance throughout the research process.
Fibroids
Elite Clinical Studies is currently at the forefront of a Fibroids Clinical Trial study in Phoenix, assisting physicians in advancing research on this common reproductive health concern. Our comprehensive support ensures smooth trial execution while maintaining strict regulatory compliance.
Endometrosis
Elite Clinical Studies is actively conducting an Endometriosis Clinical Trial study in Phoenix, providing dedicated support to physicians exploring advancements in the understanding and treatment of this challenging gynecological condition. Our commitment ensures a seamless research process while adhering to rigorous regulatory standards.
Type I or Type II Diabetes
Type I and Type II diabetes are both chronic metabolic disorders characterized by high blood sugar levels. Type I diabetes, often diagnosed in childhood or adolescence, on the other hand, Type II diabetes, typically diagnosed in adulthood.
Lipoprotein (a)
Lipoprotein (a), often abbreviated as Lp(a), is a type of lipoprotein particle that circulates in the blood. Elevated levels of Lp(a) in the blood have been associated with an increased risk of cardiovascular diseases, including heart attack and stroke.
Active Rotator Cuff Tendinopathy
Active rotator cuff tendinopathy refers to a condition characterized by inflammation and degeneration of the tendons in the rotator cuff muscles of the shoulder. It commonly occurs as a result of repetitive overhead activities or age-related wear and tear.
Acid Reflux
Acid reflux, also known as gastroesophageal reflux disease (GERD), is a condition characterized by the backflow of stomach acid into the esophagus. This occurs when the lower esophageal sphincter (LES), a muscular ring that separates the stomach from the esophagus, weakens or relaxes inappropriately.
Heartburn
Heartburn is a common symptom of acid reflux, characterized by a burning sensation in the chest or throat. It occurs when stomach acid flows back into the esophagus, causing irritation and discomfort.
Atopic Dermatitis
Atopic dermatitis, also known as eczema, is a chronic inflammatory skin condition characterized by dry, itchy, and red patches on the skin. It commonly affects individuals with a personal or family history of allergies, asthma, or hay fever.
Asthma
Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to recurrent episodes of wheezing, coughing, chest tightness, and shortness of breath. It is a condition that can range from mild to severe, and its symptoms can vary in frequency and intensity from person to person.
Erosive Esophagitis
Erosive esophagitis is a condition characterized by inflammation and damage to the lining of the esophagus. It is commonly caused by gastroesophageal reflux disease (GERD), where stomach acid flows back into the esophagus, leading to irritation and erosion of the tissue.
COPD
COPD, or chronic obstructive pulmonary disease, is a progressive lung disease characterized by persistent airflow limitation. It is often caused by long-term exposure to irritants such as cigarette smoke, air pollution, and occupational hazards.
COPD with Exacerbations
COPD with exacerbations refers to the worsening of symptoms and a sudden increase in the severity of chronic obstructive pulmonary disease (COPD). Exacerbations can be triggered by various factors, such as respiratory infections, exposure to irritants, changes in weather, or failure to adhere to treatment plans.
MACE
MACE stands for Major Adverse Cardiovascular Events. It is a term used to describe a group of serious cardiovascular events that can have significant health implications. MACE typically includes events such as heart attack, stroke, cardiovascular death, and the need for coronary revascularization procedures like angioplasty or bypass surgery.
Hypertension
Hypertension, also known as high blood pressure, is a common medical condition characterized by elevated pressure in the arteries. It is often considered a silent or asymptomatic condition, but it can have serious health implications if left untreated.
Obesity w/Type II Diabetes
Obesity and Type II diabetes often go hand in hand and can have a significant impact on an individual's health. Obesity is defined as having excess body fat, typically resulting from an imbalance between calorie intake and expenditure.
Obesity w/Cardio Vascular Disease
Obesity is a significant risk factor for cardiovascular disease (CVD), which refers to a group of conditions affecting the heart and blood vessels. Excess body weight, particularly central obesity (excess fat around the abdomen), contributes to various mechanisms that increase the risk of CVD.
GERD
GERD, which stands for gastroesophageal reflux disease, is a chronic digestive disorder characterized by the backflow of stomach acid into the esophagus. It occurs when the lower esophageal sphincter (LES), a muscular ring that separates the stomach from the esophagus, becomes weak or relaxes inappropriately.
Cardiovascular Outcomes
Chronic Idiopathic Constipation
Elite Clinical Studies in Phoenix, Arizona is currently enrolling participants for a Chronic Idiopathic Constipation (CIC) Clinical Trial Study aimed at advancing treatment options for those suffering from this persistent condition.
Ulcerative Colitis & Crohn's Disease
Elite Clinical Studies is currently enrolling qualified participants for an Ulcerative Colitis & Crohn's Disease Clinical Trial Study in Phoenix, AZ, helping advance research into potential new treatment options for these chronic inflammatory bowel diseases.

